Findings in patients with MC status
| Recipient cells, %* . | Results of sequencing DNA from granulocytes . | Recipient cells in BM, % . | Platelet no., × 109/L/platelet vol, fL . | |||
|---|---|---|---|---|---|---|
| Patient no. . | Lymphocytes . | Monocytes . | Before HST . | After HST . | ||
| 1 | 1 (230) | 2 (230) | Normal ≫ mutation (30) | ND | 2.1/5.3 | 35.9/8.8 (104) |
| 2 | 4 (540) | 60 (540) | Mutation = normal (230) | 68 (260) | 1.4/5.4 | 10.8/7.3 (671) |
| 3 | 20 (720) | 99 (720) | Mutation ≫ normal (720) | 90 (730) | 1.1/5.2 | 2.8/ND (720) |
| 4 | 0.6 (260) | 99 (260) | Mutation ≫ normal (260) | 85 (170) | 4.0/5.2 | 2.2/4.4 (279) |
| 5 | 3.5 (720) | 25 (720) | NA | 32 (310) | 3.1/6.4 | 11.0/(ND) (655) |
| 6 | 0 (920) | 10 (920) | ND | ND | 4.3/5.9 | 25.0/8.5 (859) |
| Recipient cells, %* . | Results of sequencing DNA from granulocytes . | Recipient cells in BM, % . | Platelet no., × 109/L/platelet vol, fL . | |||
|---|---|---|---|---|---|---|
| Patient no. . | Lymphocytes . | Monocytes . | Before HST . | After HST . | ||
| 1 | 1 (230) | 2 (230) | Normal ≫ mutation (30) | ND | 2.1/5.3 | 35.9/8.8 (104) |
| 2 | 4 (540) | 60 (540) | Mutation = normal (230) | 68 (260) | 1.4/5.4 | 10.8/7.3 (671) |
| 3 | 20 (720) | 99 (720) | Mutation ≫ normal (720) | 90 (730) | 1.1/5.2 | 2.8/ND (720) |
| 4 | 0.6 (260) | 99 (260) | Mutation ≫ normal (260) | 85 (170) | 4.0/5.2 | 2.2/4.4 (279) |
| 5 | 3.5 (720) | 25 (720) | NA | 32 (310) | 3.1/6.4 | 11.0/(ND) (655) |
| 6 | 0 (920) | 10 (920) | ND | ND | 4.3/5.9 | 25.0/8.5 (859) |
Values in parentheses are the number of days after HST.
BM indicates bone marrow; ND, not determined; and NA, not available because of a large deletion mutation.
WASPdim on FCM-WASP.